How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.
Relative survival varies by stage at diagnosis, from 98.7 to 25.9 percent for localized and distant stage, respectively.
Findings seen among patients <40 years with bone or soft tissue sarcomas, regardless of disease stage.
Improvement in median overall survival from 5.8 years in 1995 to 2011 to not reached in 2009 to 2017.
International disparities observed, with survival generally higher in Australia, Canada, and Norway.
Minimum-volume standards could restrict care at many centers with better-than-expected outcomes.
Overall survival 1.5 months; survival improved for those receiving chemotherapy
A population-based study compared open abdominal radical hysterectomy with minimally invasive robot-assisted radical hysterectomy, and found a slight edge in survival among those who underwent the open procedure.
Study results support the role of androgens and benefits of 5-alpha-reductase inhibition in the progression of bladder cancer.
Independent of cardiovascular risk factors, a history of cancer is a significant factor in future longevity.
